Navigation Links
Kidneys Sometimes Removed Needlessly in Patients With Rare Genetic Disorder
Date:1/11/2013

s can be disfiguring and distressing. And in some cases, angiomyolipomas lying on the kidneys can grow so large they disrupt kidney function.

But not all doctors are familiar with tuberous sclerosis, so they might mistake those growths for something more insidious.

"I had a [pediatric] patient who came to me a couple of years ago," Rabenou said. "She had angiomyolipomas in her kidneys -- and you can get massive amounts of tumors in the kidneys, sometimes you can't even see the kidneys. She went to a urologist at a major hospital nearby and was told she needed one-and-a-half kidneys removed."

Luckily, the patient was also taken to Rabenou, a specialist in tuberous sclerosis. "I told the parents I would just leave her alone," he said. "I would do an angiography and embolize the angiomyolipomas [to reduce bleeding] but I certainly would not take out her kidneys."

In other cases, Rabenou said, a partial removal of the kidney -- for example, the tissue next to an external angiomyolipoma -- would suffice instead of total removal of the organ.

Tuberous sclerosis has long been difficult to treat. But that might change: An international study published Jan. 10 in The Lancet found that the drug everolimus (Afinitor) was successful in treating kidney complications in some cases of tuberous sclerosis or a related condition.

The new study was led by Dr. John Bissler, chair of nephrology at Cincinnati Children's Hospital Medical Center, and involved adults with at least one large kidney angiomyolipoma. Participants were randomly assigned to either take everolimus or inactive placebo pills daily for about 38 weeks.

Ninety-eight patients completed the study. Of those on everolimus, 42 percent had their tumors reduced by at least half. None of the placebo patients had this response.

Novartis, the maker of everolimus, funded the study, and several of the authors are Novartis consultants.

"The drug is a big breakthrough
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Tight Blood-Sugar Control Shows Mixed Results for Health of Kidneys: Study
2. Treating Kidneys With Radio Waves May Ease Tough-to-Control Hypertension
3. Kidney cancer patients do better when whole kidney is not removed, U-M study shows
4. Black Patients More Apt to Have Voice Box Removed When Cancer Strikes
5. Higher-spending hospitals have fewer deaths for emergency patients
6. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
7. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
8. Study finds doctors have exaggerated fears when starting patients on insulin
9. Diagnostic Scans Tied to Radiation Risk for Gastro Patients
10. Predictors identified for rehospitalization among post-acute stroke patients
11. Pulse pressure elevation could presage cerebrovascular disease in Alzheimers patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Kidneys Sometimes Removed Needlessly in Patients With Rare Genetic Disorder
(Date:7/28/2014)... 2014 According to a new ... (III-V, II-VI, IV-IV, sapphire), Deposition Technology (CVD, MBE, ... Opto-electronic), Application, and Geography-2013-2020", published by MarketsandMarkets, the ... of 12.63% from 2014 to 2020 and reach ... data tables and 88 figures spread through 342 ...
(Date:7/28/2014)... July 28, 2014 The Healthcare ... graduates of its Advanced Training Program in Healthcare ... roles in their health care organization ranging from ... methodology of continuous quality improvement in the health ... Dr. Brent James’ internationally recognized Advanced Training Program ...
(Date:7/28/2014)... 28, 2014 The Europe Carotenoids & ... antioxidants market in Europe with analysis and forecast of ... in 2012 to $765.93 million by 2018, at a ... through the TOC of the Europe Carotenoids & Antioxidants ... analysis provided. It also provides a glimpse of the ...
(Date:7/28/2014)... is proposing a new theory to explain why older ... necessarily show declines in the workplace or daily life. ... are to maintain focus on cognitive tasks. , "My ... we see in cognitive performance in different settings," says ... State and author of a paper describing the theory. ...
(Date:7/28/2014)... European project SOPHIE has evaluated the relationship between ... in health in Europe. The results show that ... Europe) and countries with contradictory policies (Eastern Europe), ... reported poorer health than men. Health inequalities are ... present a 27% higher risk of having poor ...
Breaking Medicine News(10 mins):Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2Health News:Gender inequalities in health: A matter of policies 2
... Tenet Healthcare Corporation (NYSE: THC ) ... named to the company,s 2009 Circle of Excellence. ... of Excellence honors Tenet hospitals that have achieved ... performance. Key metrics used to evaluate the ...
... Life Well(SM)" Offers 10 Proven Tools to Combat Stress ... worries to family responsibilities, Americans are dealing with ever-increasing ... Mental Health America today launched an innovative public education ... stressful times. Called Live Your Life Well(SM) , ...
... Lung Cancer Alliance announced that a comprehensive ... high mortality rate was introduced with bipartisan support ... http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO )"We now ... approach to lung cancer in both Houses of ...
... Citizenship Priorities: Innovating for the Future, Enhancing Access, Safeguarding ... PARK, Ill., April 27 Abbott today announced the ... "Advancing Innovation." The report provides an update ... on the company,s mission to improve people,s lives around ...
... Argues That Best Opportunity to Maximize Shareholder Value Is ... 27 Anchor Capital, a stockholder of ... that it has sent a letter to the Board ... that BioScrip,s shareholder value would be maximized through simultaneous ...
... , The Ford Fusion Hybrid team has achieved ... gas, raising funds for the Juvenile Diabetes Research Foundation , , ... Passing the 1,000 mile mark at 9:08 a.m. this morning, the team will continue ... remaining , , , , ...
Cached Medicine News:Health News:Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award 2Health News:Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award 3Health News:New Campaign Helps Americans Deal With Stressful Times 2Health News:New Campaign Helps Americans Deal With Stressful Times 3Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 2Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 3Health News:Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report 2Health News:Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report 3Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 2Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 3Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 4Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 5Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 6Health News:Anchor Capital Calls on BioScrip Board to Pursue Cost Reductions While Exploring Strategic Sale to Unlock Shareholder Value 7Health News:One Thousand Miles and Counting: Fusion Hybrid Breaks 1,000 Miles on Single Tank, Presses on 2Health News:One Thousand Miles and Counting: Fusion Hybrid Breaks 1,000 Miles on Single Tank, Presses on 3
(Date:7/28/2014)... Germany und LONDON ... , Ziel der Zusammenarbeit sind ... genomischer Daten aus Plasmaproben zur Steuerung von Therapien ... werden kann  Neuer Bluttest basiert auf ... und soll auf Rotor-Gene Q, einer Automationsplattform der ...
(Date:7/25/2014)... , July 25, 2014  Corporate libraries are constantly ... new advancements in technology and how to cope with ... in the pharmaceutical and medical device industries are increasingly ... information and services they provide. According ... there are many forces of change that leading corporate ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, of ... Powers Lake, Wisconsin , announce ... distribution and co-marketing agreement allowing ScriptPro to bring ... the United States . ScriptPro ... and workflow systems to retail and ambulatory pharmacies. ...
Breaking Medicine Technology:QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 3QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 4QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 5QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 6QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 7Forces of Change Reshaping Corporate Libraries & Information Services 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3
Anesthesia Associates Model 100 Compact Peripheral Nerve Stimulator, incorporates the latest state-of-the-art electronics with solid state cicuitry to ensure trouble-free operation and extended batte...
... Based on the original MS-III ... electrosurgery certification, enhanced keypad ... ,The MiniStim® MS-IV peripheral ... for neuromuscular monitoring in operating ...
... is a super-light polypropylene mesh which offers ... is reduced considerably. Optilene Mesh LP is ... hernia repair procedures. It perfectly conforms,to anatomical ... Mesh LP adapts to the movements of ...
... a mesh plug to treat large or ... hernias and femoralhernias. The self-expanding plug perfectly ... completely. Premilene Mesh Self-Forming Plug is a ... Mesh. The plug corresponds with all properties ...
Medicine Products: